Sino Biopharmaceutical (OTCMKTS:SBMFF) Short Interest Down 25.1% in January

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 78,955,359 shares, a decrease of 25.1% from the December 31st total of 105,368,569 shares. Based on an average daily trading volume, of 40 shares, the days-to-cover ratio is currently 1,973,884.0 days. Currently, 0.4% of the company’s stock are short sold. Currently, 0.4% of the company’s stock are short sold. Based on an average daily trading volume, of 40 shares, the days-to-cover ratio is currently 1,973,884.0 days.

Sino Biopharmaceutical Price Performance

Shares of Sino Biopharmaceutical stock opened at $0.88 on Friday. Sino Biopharmaceutical has a 52 week low of $0.37 and a 52 week high of $1.24. The stock has a 50 day moving average price of $0.88 and a two-hundred day moving average price of $0.94.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.